Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism

NCT01458639 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Decision to change trial design.

Conditions

Pulmonary Embolism

Interventions

DRUG: Technegas V SPECT imaging
DRUG: Xenon-133 Ventilation Planar imaging

Sponsor

Cyclomedica Australia PTY Limited